Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy (Paperback)

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy discusses recently developed treatments based on molecular targets which are genetically altered in cancer cells and are essential for tumor development and survival. Considerable research effort has been devoted to the development of targeted drugs that inhibit the action of pathogenic kinases, and clinical studies performed so far have validated the positive effects of kinase inhibitors for cancer treatment. Each chapter discusses a molecular target, such as ALK2, ATR, CK, Src-Abl, EGFR, Fyn-Blk-Lyn, IGFs, and PAK1. The book's chapters are written by experts who actively work on the targets to help readers fully understand how they can be used. This is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of novel cancer therapies based on molecular targets.

General

Imprint:	Academic Press Inc
Country of origin:	United Kingdom
Release date:	May 2024
First published:	2024
Editors:	Vivek Asati • Ankur Vaidya
Dimensions:	234 x 191mm (L x W)
Format:	Paperback
Pages:	500
ISBN-13:	978-0-323-96121-9
Categories:	Books Promotions
LSN:	0-323-96121-5
Barcode:	9780323961219

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!